Article(id=1330183532837712164, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1330183519441105099, articleNumber=null, orderNo=null, doi=10.16522/j.cnki.cjph.2023.02.002, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1634659200000, receivedDateStr=2021-10-20, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1795070067843, onlineDateStr=2026-11-19, pubDate=1675958400000, pubDateStr=2023-02-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1795070067843, onlineIssueDateStr=2026-11-19, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1795070067843, creator=13701087609, updateTime=1795070067843, updator=13701087609, issue=Issue{id=1330183519441105099, tenantId=1146029695717560320, journalId=1319690259887390882, year='2023', volume='54', issue='2', pageStart='165', pageEnd='294', issueExtLink='null', onlineDate='null', pubDate='1675958400000', pubDateStr='2023-02-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1795070064649, creator='13701087609', updateTime=1795080429540, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1330226993464979643, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1330183519441105099, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1330226993464979644, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1330183519441105099, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=175, endPage=181, ext={EN=ArticleExt(id=1330183533089370405, articleId=1330183532837712164, tenantId=1146029695717560320, journalId=1319690259887390882, language=EN, title=Application of Recycle Process of Resolution-racemization in Synthesis of Chiral Drugs, columnId=1327671134809600231, journalTitle=Chinese Journal of Pharmaceuticals, columnName=Review, runingTitle=null, highlight=null, articleAbstract=

The classic resolution of racemates is one of the choices for production of chiral compounds in large scale. Due to the advantages of inexpensive and readily available of resolution agents, mature methods, simple operation, and ease of large-scale production, resolution still plays a role in the pharmaceutical industry. However, its main disadvantage is that half of the products are unwanted enantiomers, resulting in significant waste. Recycle process of resolution-racemization is a direct and effective way to remedy this disadvantage. In this paper, the applications of recycle process of resolution-racemization in synthesis of chiral drugs are reviewed based on the different mechanisms of racemization(carbanion/carbocation mechanism and mechanism of elimination-reduction).

, authors=Xunlei LYU, Kuaile LIN, Weicheng ZHOU*, authorsList=Xunlei LYU, Kuaile LIN, Weicheng ZHOU, authorCompany=null, correspAuthors=Weicheng ZHOU, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1330183533521383719, articleId=1330183532837712164, tenantId=1146029695717560320, journalId=1319690259887390882, language=CN, title=消旋-循环拆分法在手性药物合成中的应用, columnId=1327671135019315436, journalTitle=中国医药工业杂志, columnName=综述, runingTitle=null, highlight=null, articleAbstract=

拆分是制备手性药物的经典方法。由于拆分剂价格低廉易得、方法成熟、操作简便、易于大规模生产等优势,拆分在制药工业生产中仍然具有一定的地位,但其主要缺点是有另一半不需要的对映异构体产生,造成很大浪费。在消旋化后进行循环拆分,是弥补这个缺点的直接、有效途径。该文主要按不同的消旋化机制[碳负(或正)离子机制和消除还原机制],综述了消旋-循环拆分法在手性药物合成中的应用。

, authors=吕训磊, 林快乐, 周伟澄*, authorsList=吕训磊, 林快乐, 周伟澄, authorCompany=null, correspAuthors=周伟澄, authorNote=

吕训磊(1991—),男,博士研究生,专业方向:药物化学。

, correspAuthorsNote=
周伟澄(1958—),男,研究员,博士生导师,从事药物化学研究。E-mail:
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=bDRWG3L7shqTyhntYBK8UQ==, magXml=Gd6eoMHuqqMTmahOvM5R2A==, pdfUrl=null, pdf=ZWaHrWnaz8m/ywEZ3ykDNQ==, pdfFileSize=2299954, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=xyJpWYeB+JYA/evoUHBKCA==, mapNumber=null, fund=null)}, authors=[Author(id=1330183533810790700, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183532837712164, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330183533890482478, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183532837712164, authorId=1330183533810790700, language=EN, stringName=Xunlei LYU, firstName=Xunlei, middleName=null, lastName=LYU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Shanghai Key Lab. of Anti-infectives, State Key Lab. of New Drug and Pharmaceutical Process, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330183533965979952, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183532837712164, authorId=1330183533810790700, language=CN, stringName=吕训磊, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=中国医药工业研究总院上海医药工业研究院,创新药物与制药工艺国家重点实验室,上海市抗感染药物研究重点实验室,上海 201203, bio={"content":"

吕训磊(1991—),男,博士研究生,专业方向:药物化学。

"}, bioImg=null, bioContent=

吕训磊(1991—),男,博士研究生,专业方向:药物化学。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330183533722710312, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183532837712164, xref=null, ext=[AuthorCompanyExt(id=1330183533731098921, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183532837712164, companyId=1330183533722710312, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Shanghai Key Lab. of Anti-infectives, State Key Lab. of New Drug and Pharmaceutical Process, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1330183533735293226, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183532837712164, companyId=1330183533722710312, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国医药工业研究总院上海医药工业研究院,创新药物与制药工艺国家重点实验室,上海市抗感染药物研究重点实验室,上海 201203)])]), Author(id=1330183534028894514, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183532837712164, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330183534112780596, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183532837712164, authorId=1330183534028894514, language=EN, stringName=Kuaile LIN, firstName=Kuaile, middleName=null, lastName=LIN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Shanghai Key Lab. of Anti-infectives, State Key Lab. of New Drug and Pharmaceutical Process, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330183534196666677, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183532837712164, authorId=1330183534028894514, language=CN, stringName=林快乐, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=中国医药工业研究总院上海医药工业研究院,创新药物与制药工艺国家重点实验室,上海市抗感染药物研究重点实验室,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330183533722710312, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183532837712164, xref=null, ext=[AuthorCompanyExt(id=1330183533731098921, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183532837712164, companyId=1330183533722710312, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Shanghai Key Lab. of Anti-infectives, State Key Lab. of New Drug and Pharmaceutical Process, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1330183533735293226, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183532837712164, companyId=1330183533722710312, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国医药工业研究总院上海医药工业研究院,创新药物与制药工艺国家重点实验室,上海市抗感染药物研究重点实验室,上海 201203)])]), Author(id=1330183534259581240, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183532837712164, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=zhouweicheng58@163.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330183534335078714, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183532837712164, authorId=1330183534259581240, language=EN, stringName=Weicheng ZHOU, firstName=Weicheng, middleName=null, lastName=ZHOU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=Shanghai Key Lab. of Anti-infectives, State Key Lab. of New Drug and Pharmaceutical Process, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330183534448324923, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183532837712164, authorId=1330183534259581240, language=CN, stringName=周伟澄, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=中国医药工业研究总院上海医药工业研究院,创新药物与制药工艺国家重点实验室,上海市抗感染药物研究重点实验室,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330183533722710312, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183532837712164, xref=null, ext=[AuthorCompanyExt(id=1330183533731098921, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183532837712164, companyId=1330183533722710312, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Shanghai Key Lab. of Anti-infectives, State Key Lab. of New Drug and Pharmaceutical Process, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1330183533735293226, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183532837712164, companyId=1330183533722710312, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国医药工业研究总院上海医药工业研究院,创新药物与制药工艺国家重点实验室,上海市抗感染药物研究重点实验室,上海 201203)])])], keywords=[Keyword(id=1330183534553182524, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183532837712164, language=EN, orderNo=1, keyword=racemization), Keyword(id=1330183534637068605, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183532837712164, language=EN, orderNo=2, keyword=recycle process of resolution), Keyword(id=1330183534741926206, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183532837712164, language=EN, orderNo=3, keyword=carbanion/carbocation mechanism), Keyword(id=1330183534863561023, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183532837712164, language=EN, orderNo=4, keyword=mechanism of elimination-reduction), Keyword(id=1330183535048110400, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183532837712164, language=CN, orderNo=1, keyword=消旋化), Keyword(id=1330183536683888962, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183532837712164, language=CN, orderNo=2, keyword=循环拆分), Keyword(id=1330183536763580739, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183532837712164, language=CN, orderNo=3, keyword=碳负(或正)离子机制), Keyword(id=1330183536826495300, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183532837712164, language=CN, orderNo=4, keyword=消除还原机制)], refs=[Reference(id=1330183536935547205, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183532837712164, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=刘潍源,林快乐,许文倩,等.2020 年美国 FDA 批准上市的新药简介[J].中国医药工业杂志,2021,52(1):1-31., articleTitle=null, refAbstract=null), Reference(id=1330183537057182022, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183532837712164, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=吕训磊,周伟澄,林快乐.2019 年美国 FDA 批准上市的新药简介[J].中国医药工业杂志,2020,51(1):1-29., articleTitle=null, refAbstract=null), Reference(id=1330183537132679495, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183532837712164, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=吕训磊,林快乐,郭琳琳,等.2018 年美国 FDA 批准上市的新药简介[J].中国医药工业杂志,2019,50(1):1-33., articleTitle=null, refAbstract=null), Reference(id=1330183537191399752, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183532837712164, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=吕训磊,郭琳琳,周伟澄.2017 年美国 FDA 批准上市的新药简介[J].中国医药工业杂志,2018, 49(1):1-28., articleTitle=null, refAbstract=null), Reference(id=1330183537279480137, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183532837712164, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=邓艳芳,吴桐,李泽文,等.手性拆分技术-化学拆分法的研究进展[J].沈阳药科大学学报,2019, 36(11):1056-1060., articleTitle=null, refAbstract=null), Reference(id=1330183537350783306, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183532837712164, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=JAIN N, XU J, KANOJIA R M, et al. Identification and structure-activity relationships of chromene-derived selective estrogen receptor modulators for treatment of postmenopausal symptoms [J]. J Med Chem, 2009, 52(23): 7544-7569., articleTitle=null, refAbstract=null), Reference(id=1330183537417892171, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183532837712164, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=LI X, RUSSELL R K, HORVATH A, et al. Synthesis of tetracyclic heterocompounds as selective estrogen receptor modulators. Part 3. Development of an acid-catalyzed racemization process for (S)-2,8-(dimethoxy)-5-{4-[2-(1-piperidinyl)ethoxy]-phenyl}-11,12-dihydro-5H-6,13-dioxabenzo[3,4]cyclohepta[1,2-a]naphthalene [J]. Org Process Res Dev, 2009, 13(1): 102-105., articleTitle=null, refAbstract=null), Reference(id=1330183537510166860, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183532837712164, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=倪峰.利用循环拆分法合成(R)-阿朴吗啡和(R)-阿朴啡及它们衍生物[D].上海:华东理工大学博士学位论文,2007, articleTitle=null, refAbstract=null), Reference(id=1330183537577275725, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183532837712164, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=SHI X, NI F, SHANG H, et al. Racemization of (S)-(+)-10,11-dimethoxyaporphine and (S)-(+)-aporphine:efficient preparations of (R)-(–)-apomorphine and (R)-(–)-aporphine via a recycle process of resolution [J]. Tetrahedron: Asymm, 2006, 17(15): 2210-2215., articleTitle=null, refAbstract=null), Reference(id=1330183537640190286, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183532837712164, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=LV X, CHEN L, PAN J, et al. Efficient preparation of (R)-2-(2,5-difluorophenyl) pyrrolidine via a recycle process of resolution [J]. Chirality, 2021, 33(12): 931-937., articleTitle=null, refAbstract=null), Reference(id=1330183537711493455, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183532837712164, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=LUNDRIGAN T, WELSH E N, HYNES T, et al. Enantioselective imine reduction catalyzed by phosphenium ions [J]. J Am Chem Soc, 2019, 141(36): 14083-14088., articleTitle=null, refAbstract=null), Reference(id=1330183537770213712, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183532837712164, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=WĘGLARZ I, MICHALAK K , MLYNARSKI J. Zinc-catalyzed asymmetric hydrosilylation of cyclic imines:synthesis of chiral 2-aryl-substituted pyrrolidines as pharmaceutical building blocks [J]. Adv Synth Catal, 2021,363(5): 1317-1321., articleTitle=null, refAbstract=null), Reference(id=1330183537824739665, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183532837712164, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHANG Y, CHEN F, LI B, et al. Stereocomplementary synthesis of pharmaceutically relevant chiral 2-aryl-substituted pyrrolidines using imine reductases [J]. Org Lett, 2020, 22(9): 3367-3372., articleTitle=null, refAbstract=null), Reference(id=1330183537887654226, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183532837712164, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=UCHIKAWA O, FUKATSU K, TOKUNOH R, et al. Synthesis of a novel series of tricyclic indan derivatives as melatonin receptor agonists [J]. J Med Chem, 2002,45(19): 4222-4239., articleTitle=null, refAbstract=null), Reference(id=1330183537967346003, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183532837712164, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=丁胜,王娜,周亭,等.雷美替胺中间体拆分副产物的消旋化[J].中国医药工业杂志,2016,47(5):531-534., articleTitle=null, refAbstract=null), Reference(id=1330183538097369428, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183532837712164, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=王堃,邹龙,刘根炎,等.莫西沙星及其杂质的合成研究进展[J].化学通报,2018,81(5):414-424., articleTitle=null, refAbstract=null), Reference(id=1330183538252558677, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183532837712164, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=CHEN S, LIU D, SI L, et al. Efficient synthesis of (S, S)-2,8-diazabicyclo[4.3.0]nonane [J]. Synthetic Commun,2017, 47(3): 238-244., articleTitle=null, refAbstract=null), Reference(id=1330183538332250454, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183532837712164, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=王保成,袁鹏,贾建国,等.(S)-型四氢异喹啉的回收方法:中国,102491945 [P].2012-06-13., articleTitle=null, refAbstract=null), Reference(id=1330183538390970711, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183532837712164, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=NAITO R, YONETOKU Y, OKAMOTO Y, et al. Synthesis and antimuscarinic properties of quinuclidin-3-yl-1,2,3,4-tetrahydroisoquinoline-2-carboxylate derivatives as novel muscarinic receptor antagonists [J]. J Med Chem, 2005,48(21): 6597-6606., articleTitle=null, refAbstract=null), Reference(id=1330183538470662488, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183532837712164, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=李强,朱金林,黄伟,等.琥珀酸索非那新的合成[J].中国医药工业杂志,2012,43(1):1-4., articleTitle=null, refAbstract=null), Reference(id=1330183538541965657, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183532837712164, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=BOLCHI C, PALLAVICINI M, FUMAGALLI L, et al. One-pot racemization process of 1-phenyl-1,2,3,4-tetrahydroisoquinoline: a key intermediate for the antimuscarinic agent solifenacin [J]. Org Process Res Dev,2013, 17(3): 432-437., articleTitle=null, refAbstract=null), Reference(id=1330183538609074522, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183532837712164, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHU R, XU Z, WEI D, et al. Efficient and practical syntheses of enantiomerically pure (S)-(–)-norcryptostyline I, (S)-(–)-norcryptostyline Ⅱ, (R)-(+)-salsolidine and(S)-(–)-norlaudanosine via a resolution-racemization method [J]. Chinese J Chem, 2015, 32(10): 1039-1048., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1330183533722710312, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183532837712164, xref=null, ext=[AuthorCompanyExt(id=1330183533731098921, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183532837712164, companyId=1330183533722710312, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Shanghai Key Lab. of Anti-infectives, State Key Lab. of New Drug and Pharmaceutical Process, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1330183533735293226, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183532837712164, companyId=1330183533722710312, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国医药工业研究总院上海医药工业研究院,创新药物与制药工艺国家重点实验室,上海市抗感染药物研究重点实验室,上海 201203)])], figs=null, attaches=null, journal=Journal(id=1319689822849302687, delFlag=0, nameCn=中国医药工业杂志, nameEn=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, issn=1001-8255, eissn=null, cn=31-1243/R, coden=ZYGZEA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=etiWDuwx2KO274LHw88KJA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Pharmaceuticals, journalRemark=null, publicationField=null, createdTime=1792568172420, updatedTime=1792747450744, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=etiWDuwx2KO274LHw88KJA==, picEn=ip9NF4dK57AmNrCiZ6hmdw==, jcr=null, cjcr=null, exts=[JournalExt(id=1320441770761105589, language=CN, name=中国医药工业杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450771, updatedTime=1792747450771, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1320441770819825846, language=EN, name=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450785, updatedTime=1792747450785, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1319690259887390882, websiteList=[Website(id=1319720771623174732, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/CN, language=CN, createTime=1792575551181, createBy=18614031015, updateTime=1792746040843, updateBy=18614031015, name=中国医药工业杂志-中文, tplId=1146099689490845704, title=中国医药工业杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428487504769041, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=articleTextType, value=kx, createTime=1792982702375, updateTime=1792982702375, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487475408910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982702368, updateTime=1792982702368, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487538323476, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=grayFlag, value=0, createTime=1792982702383, updateTime=1792982702383, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487462825997, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982702365, updateTime=1792982702365, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487571877910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=minRunFlag, value=0, createTime=1792982702391, updateTime=1792982702391, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487496380432, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic, createTime=1792982702373, updateTime=1792982702373, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487563489301, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=silenceFlag, value=0, createTime=1792982702389, updateTime=1792982702389, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487483797519, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982702370, updateTime=1792982702370, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487517351954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeColor, value=null, createTime=1792982702378, updateTime=1792982702378, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487525740563, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982702380, updateTime=1792982702380, creator=18614031015, updator=18614031015)]), Website(id=1319720771702866512, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/EN, language=EN, createTime=1792575551200, createBy=18614031015, updateTime=1792746037543, updateBy=18614031015, name=中国医药工业杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Pharmaceuticals, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428509638111261, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=articleTextType, value=kx, createTime=1792982707652, updateTime=1792982707652, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509579391002, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982707638, updateTime=1792982707638, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509680054304, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=grayFlag, value=0, createTime=1792982707662, updateTime=1792982707662, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509566808089, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982707635, updateTime=1792982707635, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509701025826, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=minRunFlag, value=0, createTime=1792982707667, updateTime=1792982707667, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509629722652, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic, createTime=1792982707650, updateTime=1792982707650, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509688442913, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=silenceFlag, value=0, createTime=1792982707664, updateTime=1792982707664, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509587779611, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982707640, updateTime=1792982707640, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509663277086, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeColor, value=null, createTime=1792982707658, updateTime=1792982707658, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509671665695, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982707660, updateTime=1792982707660, creator=18614031015, updator=18614031015)])], journalTitle=中国医药工业杂志, weixinUrl=null, journalUrl=http://www.cjph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Pharmaceuticals, journalPhotoCn=etiWDuwx2KO274LHw88KJA==, journalPhotoEn=ip9NF4dK57AmNrCiZ6hmdw==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2023.02.002, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2023.02.002, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/PDF/10.16522/j.cnki.cjph.2023.02.002, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/PDF/10.16522/j.cnki.cjph.2023.02.002, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1675958400000, fullTextJson=null, articleText=null, reference=null)
收藏切换
消旋-循环拆分法在手性药物合成中的应用
吕训磊 , 林快乐 , 周伟澄 *
中国医药工业杂志 | 综述 2023,54(2): 175-181
收起
收藏切换
中国医药工业杂志 |综述 2023 , 54 (2) : 175 -181
消旋-循环拆分法在手性药物合成中的应用
全屏
[Author(id=1330183533810790700, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183532837712164, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330183533890482478, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183532837712164, authorId=1330183533810790700, language=EN, stringName=Xunlei LYU, firstName=Xunlei, middleName=null, lastName=LYU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Shanghai Key Lab. of Anti-infectives, State Key Lab. of New Drug and Pharmaceutical Process, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330183533965979952, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183532837712164, authorId=1330183533810790700, language=CN, stringName=吕训磊, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=中国医药工业研究总院上海医药工业研究院,创新药物与制药工艺国家重点实验室,上海市抗感染药物研究重点实验室,上海 201203, bio={"content":"

吕训磊(1991—),男,博士研究生,专业方向:药物化学。

"}, bioImg=null, bioContent=

吕训磊(1991—),男,博士研究生,专业方向:药物化学。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330183533722710312, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183532837712164, xref=null, ext=[AuthorCompanyExt(id=1330183533731098921, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183532837712164, companyId=1330183533722710312, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Shanghai Key Lab. of Anti-infectives, State Key Lab. of New Drug and Pharmaceutical Process, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1330183533735293226, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183532837712164, companyId=1330183533722710312, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国医药工业研究总院上海医药工业研究院,创新药物与制药工艺国家重点实验室,上海市抗感染药物研究重点实验室,上海 201203)])]), Author(id=1330183534028894514, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183532837712164, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330183534112780596, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183532837712164, authorId=1330183534028894514, language=EN, stringName=Kuaile LIN, firstName=Kuaile, middleName=null, lastName=LIN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Shanghai Key Lab. of Anti-infectives, State Key Lab. of New Drug and Pharmaceutical Process, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330183534196666677, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183532837712164, authorId=1330183534028894514, language=CN, stringName=林快乐, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=中国医药工业研究总院上海医药工业研究院,创新药物与制药工艺国家重点实验室,上海市抗感染药物研究重点实验室,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330183533722710312, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183532837712164, xref=null, ext=[AuthorCompanyExt(id=1330183533731098921, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183532837712164, companyId=1330183533722710312, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Shanghai Key Lab. of Anti-infectives, State Key Lab. of New Drug and Pharmaceutical Process, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1330183533735293226, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183532837712164, companyId=1330183533722710312, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国医药工业研究总院上海医药工业研究院,创新药物与制药工艺国家重点实验室,上海市抗感染药物研究重点实验室,上海 201203)])]), Author(id=1330183534259581240, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183532837712164, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=zhouweicheng58@163.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330183534335078714, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183532837712164, authorId=1330183534259581240, language=EN, stringName=Weicheng ZHOU, firstName=Weicheng, middleName=null, lastName=ZHOU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=Shanghai Key Lab. of Anti-infectives, State Key Lab. of New Drug and Pharmaceutical Process, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330183534448324923, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183532837712164, authorId=1330183534259581240, language=CN, stringName=周伟澄, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=中国医药工业研究总院上海医药工业研究院,创新药物与制药工艺国家重点实验室,上海市抗感染药物研究重点实验室,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330183533722710312, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183532837712164, xref=null, ext=[AuthorCompanyExt(id=1330183533731098921, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183532837712164, companyId=1330183533722710312, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Shanghai Key Lab. of Anti-infectives, State Key Lab. of New Drug and Pharmaceutical Process, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1330183533735293226, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183532837712164, companyId=1330183533722710312, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国医药工业研究总院上海医药工业研究院,创新药物与制药工艺国家重点实验室,上海市抗感染药物研究重点实验室,上海 201203)])])]
吕训磊, 林快乐, 周伟澄*
作者信息
  • 中国医药工业研究总院上海医药工业研究院,创新药物与制药工艺国家重点实验室,上海市抗感染药物研究重点实验室,上海 201203
通讯作者:
周伟澄(1958—),男,研究员,博士生导师,从事药物化学研究。E-mail:
作者简介:

吕训磊(1991—),男,博士研究生,专业方向:药物化学。

Application of Recycle Process of Resolution-racemization in Synthesis of Chiral Drugs
Xunlei LYU, Kuaile LIN, Weicheng ZHOU*
Affiliations
  • Shanghai Key Lab. of Anti-infectives, State Key Lab. of New Drug and Pharmaceutical Process, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 201203
出版时间: 2023-02-10 doi: 10.16522/j.cnki.cjph.2023.02.002
文章导航
收藏切换

拆分是制备手性药物的经典方法。由于拆分剂价格低廉易得、方法成熟、操作简便、易于大规模生产等优势,拆分在制药工业生产中仍然具有一定的地位,但其主要缺点是有另一半不需要的对映异构体产生,造成很大浪费。在消旋化后进行循环拆分,是弥补这个缺点的直接、有效途径。该文主要按不同的消旋化机制[碳负(或正)离子机制和消除还原机制],综述了消旋-循环拆分法在手性药物合成中的应用。

消旋化  /  循环拆分  /  碳负(或正)离子机制  /  消除还原机制

The classic resolution of racemates is one of the choices for production of chiral compounds in large scale. Due to the advantages of inexpensive and readily available of resolution agents, mature methods, simple operation, and ease of large-scale production, resolution still plays a role in the pharmaceutical industry. However, its main disadvantage is that half of the products are unwanted enantiomers, resulting in significant waste. Recycle process of resolution-racemization is a direct and effective way to remedy this disadvantage. In this paper, the applications of recycle process of resolution-racemization in synthesis of chiral drugs are reviewed based on the different mechanisms of racemization(carbanion/carbocation mechanism and mechanism of elimination-reduction).

racemization  /  recycle process of resolution  /  carbanion/carbocation mechanism  /  mechanism of elimination-reduction
吕训磊, 林快乐, 周伟澄. 消旋-循环拆分法在手性药物合成中的应用. 中国医药工业杂志, 2023 , 54 (2) : 175 -181 . DOI: 10.16522/j.cnki.cjph.2023.02.002
Xunlei LYU, Kuaile LIN, Weicheng ZHOU. Application of Recycle Process of Resolution-racemization in Synthesis of Chiral Drugs[J]. Chinese Journal of Pharmaceuticals, 2023 , 54 (2) : 175 -181 . DOI: 10.16522/j.cnki.cjph.2023.02.002

参考文献 引证文献
排序方式:
[1]
刘潍源,林快乐,许文倩,等.2020 年美国 FDA 批准上市的新药简介[J].中国医药工业杂志,2021,52(1):1-31.
[2]
吕训磊,周伟澄,林快乐.2019 年美国 FDA 批准上市的新药简介[J].中国医药工业杂志,2020,51(1):1-29.
[3]
吕训磊,林快乐,郭琳琳,等.2018 年美国 FDA 批准上市的新药简介[J].中国医药工业杂志,2019,50(1):1-33.
[4]
吕训磊,郭琳琳,周伟澄.2017 年美国 FDA 批准上市的新药简介[J].中国医药工业杂志,2018, 49(1):1-28.
[5]
邓艳芳,吴桐,李泽文,等.手性拆分技术-化学拆分法的研究进展[J].沈阳药科大学学报,2019, 36(11):1056-1060.
[6]
JAIN N, XU J, KANOJIA R M, et al. Identification and structure-activity relationships of chromene-derived selective estrogen receptor modulators for treatment of postmenopausal symptoms [J]. J Med Chem, 2009, 52(23): 7544-7569.
[7]
LI X, RUSSELL R K, HORVATH A, et al. Synthesis of tetracyclic heterocompounds as selective estrogen receptor modulators. Part 3. Development of an acid-catalyzed racemization process for (S)-2,8-(dimethoxy)-5-{4-[2-(1-piperidinyl)ethoxy]-phenyl}-11,12-dihydro-5H-6,13-dioxabenzo[3,4]cyclohepta[1,2-a]naphthalene [J]. Org Process Res Dev, 2009, 13(1): 102-105.
[8]
倪峰.利用循环拆分法合成(R)-阿朴吗啡和(R)-阿朴啡及它们衍生物[D].上海:华东理工大学博士学位论文,2007
[9]
SHI X, NI F, SHANG H, et al. Racemization of (S)-(+)-10,11-dimethoxyaporphine and (S)-(+)-aporphine:efficient preparations of (R)-(–)-apomorphine and (R)-(–)-aporphine via a recycle process of resolution [J]. Tetrahedron: Asymm, 2006, 17(15): 2210-2215.
[10]
LV X, CHEN L, PAN J, et al. Efficient preparation of (R)-2-(2,5-difluorophenyl) pyrrolidine via a recycle process of resolution [J]. Chirality, 2021, 33(12): 931-937.
[11]
LUNDRIGAN T, WELSH E N, HYNES T, et al. Enantioselective imine reduction catalyzed by phosphenium ions [J]. J Am Chem Soc, 2019, 141(36): 14083-14088.
[12]
WĘGLARZ I, MICHALAK K , MLYNARSKI J. Zinc-catalyzed asymmetric hydrosilylation of cyclic imines:synthesis of chiral 2-aryl-substituted pyrrolidines as pharmaceutical building blocks [J]. Adv Synth Catal, 2021,363(5): 1317-1321.
[13]
ZHANG Y, CHEN F, LI B, et al. Stereocomplementary synthesis of pharmaceutically relevant chiral 2-aryl-substituted pyrrolidines using imine reductases [J]. Org Lett, 2020, 22(9): 3367-3372.
[14]
UCHIKAWA O, FUKATSU K, TOKUNOH R, et al. Synthesis of a novel series of tricyclic indan derivatives as melatonin receptor agonists [J]. J Med Chem, 2002,45(19): 4222-4239.
[15]
丁胜,王娜,周亭,等.雷美替胺中间体拆分副产物的消旋化[J].中国医药工业杂志,2016,47(5):531-534.
[16]
王堃,邹龙,刘根炎,等.莫西沙星及其杂质的合成研究进展[J].化学通报,2018,81(5):414-424.
[17]
CHEN S, LIU D, SI L, et al. Efficient synthesis of (S, S)-2,8-diazabicyclo[4.3.0]nonane [J]. Synthetic Commun,2017, 47(3): 238-244.
[18]
王保成,袁鹏,贾建国,等.(S)-型四氢异喹啉的回收方法:中国,102491945 [P].2012-06-13.
[19]
NAITO R, YONETOKU Y, OKAMOTO Y, et al. Synthesis and antimuscarinic properties of quinuclidin-3-yl-1,2,3,4-tetrahydroisoquinoline-2-carboxylate derivatives as novel muscarinic receptor antagonists [J]. J Med Chem, 2005,48(21): 6597-6606.
[20]
李强,朱金林,黄伟,等.琥珀酸索非那新的合成[J].中国医药工业杂志,2012,43(1):1-4.
[21]
BOLCHI C, PALLAVICINI M, FUMAGALLI L, et al. One-pot racemization process of 1-phenyl-1,2,3,4-tetrahydroisoquinoline: a key intermediate for the antimuscarinic agent solifenacin [J]. Org Process Res Dev,2013, 17(3): 432-437.
[22]
ZHU R, XU Z, WEI D, et al. Efficient and practical syntheses of enantiomerically pure (S)-(–)-norcryptostyline I, (S)-(–)-norcryptostyline Ⅱ, (R)-(+)-salsolidine and(S)-(–)-norlaudanosine via a resolution-racemization method [J]. Chinese J Chem, 2015, 32(10): 1039-1048.
2023年第54卷第2期
23
6
0
引用本文
BibTeX
文章信息
doi: 10.16522/j.cnki.cjph.2023.02.002
  • 接收时间:2021-10-20
  • 首发时间:2026-11-19
  • 出版时间:2023-02-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2021-10-20
基金
作者信息
    中国医药工业研究总院上海医药工业研究院,创新药物与制药工艺国家重点实验室,上海市抗感染药物研究重点实验室,上海 201203

通讯作者:

周伟澄(1958—),男,研究员,博士生导师,从事药物化学研究。E-mail:
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2023.02.002
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏